Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhinoconjunctivitis, Allergic”

209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 209 results

Testing effectiveness (Phase 2)Study completedNCT04532710
What this trial is testing

Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis

Who this might be right for
Allergic ConjunctivitisAllergic Rhinitis
Marinomed Biotech AG 64
Testing effectiveness (Phase 2)Study completedNCT01921257
What this trial is testing

Paediatric Safety Study in Cat-PAD

Who this might be right for
Rhinoconjunctivitis
Circassia Limited 16
Testing effectiveness (Phase 2)Study completedNCT01385800
What this trial is testing

ToleroMune Grass Exposure Unit Study

Who this might be right for
Grass AllergyRhinoconjunctivitis
Circassia Limited 280
Testing effectiveness (Phase 2)Study completedNCT02311413
What this trial is testing

Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Who this might be right for
Cat AllergyCat Hypersensitivity
National Institute of Allergy and Infectious Diseases (NIAID) 39
Large-scale testing (Phase 3)Study completedNCT00803244
What this trial is testing

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Who this might be right for
Primary Disease
Stallergenes Greer 381
Testing effectiveness (Phase 2)Study completedNCT01308021
What this trial is testing

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Who this might be right for
Grass Pollen AllergyHay Fever
BioTech Tools S.A. 202
Large-scale testing (Phase 3)Study completedNCT05540717
What this trial is testing

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen

Who this might be right for
Seasonal Allergic RhinitisRhinoconjunctivitis
Allergy Therapeutics 555
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Not applicableStudy completedNCT02396680
What this trial is testing

Ragweed-SPIRE Follow-On Study

Who this might be right for
RhinoconjunctivitisRagweed Allergy
Circassia Limited 249
Not applicableStudy completedNCT04898686
What this trial is testing

Probiotic Chewables in Allergic Rhinoconjunctivitis Patients

Who this might be right for
Allergic Rhinoconjunctivitis
University Hospital, Antwerp 64
Large-scale testing (Phase 3)Study completedNCT05668390
What this trial is testing

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

Who this might be right for
Allergic RhinoconjunctivitisBirch Pollen Allergy
Stallergenes Greer 553
Not applicableStudy completedNCT01085526
What this trial is testing

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Who this might be right for
Allergic Rhinoconjunctivitis
Aarhus University Hospital 30
Not applicableStudy completedNCT01535118
What this trial is testing

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)

Who this might be right for
Allergic Rhinoconjunctivitis
ALK-Abelló A/S 2,765
Large-scale testing (Phase 3)Looking for participantsNCT04435990
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites

Who this might be right for
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L. 150
Large-scale testing (Phase 3)Study completedNCT00567346
What this trial is testing

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Who this might be right for
Allergic Rhinoconjunctivitis
Artu Biologicals 605
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Large-scale testing (Phase 3)Study completedNCT04145219
What this trial is testing

House Dust Mite Allergy Trial In Children

Who this might be right for
Allergic Rhinitis Due to Dermatophagoides FarinaeAllergic Rhinitis Due to Dermatophagoides PteronyssinusAllergic Rhinitis Due to House Dust Mite
ALK-Abelló A/S 1,460
Large-scale testing (Phase 3)UnknownNCT05400811
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Who this might be right for
House Dust Mite AllergyPerennial Allergic RhinitisAllergic Rhinoconjunctivitis+1 more
Inmunotek S.L. 400
Testing effectiveness (Phase 2)Study completedNCT00470457
What this trial is testing

Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Who this might be right for
Rhinoconjunctivitis Due to Grass Pollen Allergy
University of Zurich 156
Large-scale testing (Phase 3)Study completedNCT01353079
What this trial is testing

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Who this might be right for
Allergy
Greer Laboratories 429
Next Page